Annual CFF
-$407.20 K
-$251.60 K-161.70%
31 December 2023
Summary:
MiNK Therapeutics annual cash flow from financing activities is currently -$407.20 thousand, with the most recent change of -$251.60 thousand (-161.70%) on 31 December 2023. During the last 3 years, it has fallen by -$11.51 million (-103.67%). INKT annual CFF is now -100.83% below its all-time high of $49.26 million, reached on 31 December 2021.INKT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$6800.00
-$5.80 M-99.88%
30 September 2024
Summary:
MiNK Therapeutics quarterly cash flow from financing activities is currently $6800.00, with the most recent change of -$5.80 million (-99.88%) on 30 September 2024. Over the past year, it has increased by +$3800.00 (+126.67%). INKT quarterly CFF is now -99.98% below its all-time high of $39.80 million, reached on 31 December 2021.INKT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$10.82 M
+$3800.00+0.04%
30 September 2024
Summary:
MiNK Therapeutics TTM cash flow from financing activities is currently $10.82 million, with the most recent change of +$3800.00 (+0.04%) on 30 September 2024. Over the past year, it has increased by +$11.23 million (+2758.48%). INKT TTM CFF is now -78.03% below its all-time high of $49.26 million, reached on 31 December 2021.INKT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INKT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -161.7% | +126.7% | +2758.5% |
| 3 y3 years | -103.7% | -99.8% | +14.4% |
| 5 y5 years | - | - | - |
INKT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.8% | at low | -100.0% | +102.0% | -78.0% | +2305.0% |
| 5 y | 5 years | -100.8% | at low | -100.0% | +102.0% | -78.0% | +2305.0% |
| alltime | all time | -100.8% | at low | -100.0% | +102.0% | -78.0% | +2305.0% |
MiNK Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6800.00(-99.9%) | $10.82 M(+0.0%) |
| June 2024 | - | $5.81 M(+16.0%) | $10.82 M(+119.2%) |
| Mar 2024 | - | $5.01 M(>+9900.0%) | $4.93 M(-1312.0%) |
| Dec 2023 | -$407.20 K(+161.7%) | $0.00(-100.0%) | -$407.10 K(+0.0%) |
| Sept 2023 | - | $3000.00(-104.0%) | -$407.00 K(-0.6%) |
| June 2023 | - | -$75.70 K(-77.4%) | -$409.50 K(-16.5%) |
| Mar 2023 | - | -$334.40 K(<-9900.0%) | -$490.70 K(+215.4%) |
| Dec 2022 | -$155.60 K | $100.00(-80.0%) | -$155.60 K(-100.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $500.00(-100.3%) | $39.64 M(-6.6%) |
| June 2022 | - | -$156.90 K(<-9900.0%) | $42.42 M(-9.6%) |
| Mar 2022 | - | $700.00(-100.0%) | $46.93 M(-4.7%) |
| Dec 2021 | $49.26 M(+343.5%) | $39.80 M(+1330.1%) | $49.26 M(+420.7%) |
| Sept 2021 | - | $2.78 M(-36.1%) | $9.46 M(+41.7%) |
| June 2021 | - | $4.35 M(+87.2%) | $6.68 M(+187.2%) |
| Mar 2021 | - | $2.32 M | $2.32 M |
| Dec 2020 | $11.11 M(-2.9%) | - | - |
| Dec 2019 | $11.44 M | - | - |
FAQ
- What is MiNK Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for MiNK Therapeutics?
- What is MiNK Therapeutics annual CFF year-on-year change?
- What is MiNK Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly CFF year-on-year change?
- What is MiNK Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for MiNK Therapeutics?
- What is MiNK Therapeutics TTM CFF year-on-year change?
What is MiNK Therapeutics annual cash flow from financing activities?
The current annual CFF of INKT is -$407.20 K
What is the all time high annual CFF for MiNK Therapeutics?
MiNK Therapeutics all-time high annual cash flow from financing activities is $49.26 M
What is MiNK Therapeutics annual CFF year-on-year change?
Over the past year, INKT annual cash flow from financing activities has changed by -$251.60 K (-161.70%)
What is MiNK Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of INKT is $6800.00
What is the all time high quarterly CFF for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly cash flow from financing activities is $39.80 M
What is MiNK Therapeutics quarterly CFF year-on-year change?
Over the past year, INKT quarterly cash flow from financing activities has changed by +$3800.00 (+126.67%)
What is MiNK Therapeutics TTM cash flow from financing activities?
The current TTM CFF of INKT is $10.82 M
What is the all time high TTM CFF for MiNK Therapeutics?
MiNK Therapeutics all-time high TTM cash flow from financing activities is $49.26 M
What is MiNK Therapeutics TTM CFF year-on-year change?
Over the past year, INKT TTM cash flow from financing activities has changed by +$11.23 M (+2758.48%)